Welcome to LookChem.com Sign In|Join Free
  • or
1-benzyloxyindane-4-boronic acid is a chemical with a specific purpose. Lookchem provides you with multiple data and supplier information of this chemical.

675845-92-8

Post Buying Request

675845-92-8 Suppliers

Recommended suppliers

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

675845-92-8 Usage

Type of compound

Boronic acid derivative

Structure

Contains a boron atom attached to a benzene ring and an indane moiety

Organic synthesis

As a reagent for forming carbon-carbon and carbon-heteroatom bonds

Pharmaceutical development

For modifying and enhancing the biological activity of certain organic molecules

Agrochemical development

For modifying and enhancing the biological activity of certain organic molecules

Application

Versatile and valuable chemical building block for the synthesis of a wide range of organic compounds

Check Digit Verification of cas no

The CAS Registry Mumber 675845-92-8 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 6,7,5,8,4 and 5 respectively; the second part has 2 digits, 9 and 2 respectively.
Calculate Digit Verification of CAS Registry Number 675845-92:
(8*6)+(7*7)+(6*5)+(5*8)+(4*4)+(3*5)+(2*9)+(1*2)=218
218 % 10 = 8
So 675845-92-8 is a valid CAS Registry Number.

675845-92-8Relevant academic research and scientific papers

Structure-Activity Relationships of Potent, Selective Inhibitors of Neuronal Nitric Oxide Synthase Based on the 6-Phenyl-2-aminopyridine Structure

Lowe III, John A.,Qian, Weimin,Drozda, Susan E.,Volkmann, Robert A.,Nason, Deane,Nelson, Robert B.,Nolan, Charles,Liston, Dane,Ward, Karen,Faraci, Steve,Verdries, Kim,Seymour, Pat,Majchrzak, Michael,Villalobos, Anabella,White, W. Frost

, p. 1575 - 1586 (2007/10/03)

The synthesis and structure-activity relationships of a series of 6-phenyl-2-aminopyridines that potently and selectively inhibit the neuronal isoform of nitric oxide synthase (nNOS) are described. Compound 14bi from this series exhibits potent in vivo activity in harmaline-induced cGMP formation in rat cerebellum, a functional model of nNOS inhibition, and in the PCP-induced hypermotility model in the rat. These results suggest that 14bi may be a useful reagent for evaluating potential therapeutic applications of nNOS inhibitors in the central nervous system.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1 Customer Service

What can I do for you?
Get Best Price

Get Best Price for 675845-92-8